This is a problem and I agree. Most of our portfolio companies are concerned that COVID is temporary and are seeking alternative business models in parallel. This is because institutional investors, who will ultimately end up funding the companies down the road due to Reg C funding limited to $1M/yr, continue to tell startups that need to have alternative business models in case a vaccine is approved. To some extent, trying to move away from the deeply entrenched institutional investment model is an ouroboros.
No comments yet.